819 Induction carboplatin-paclitaxel-gemcitabine (CPG) followed by concurrent weekly carboplatin-paclifaxel (CP) and radiation therapy in unresectable stage iii non-small cell lung cancer (NSCLC). A phase II study

O.Francesco; A.Paccagnella; S.Fasan; S.Ardit; C.Gatti; R.Biason; M.Medici; P.dAmanzo; M.G.Ghi; O.Nasicmben

首页> 外文期刊>European Journal of Cancer Supplements >819 Induction carboplatin-paclitaxel-gemcitabine (CPG) followed by concurrent weekly carboplatin-paclifaxel (CP) and radiation therapy in unresectable stage iii non-small cell lung cancer (NSCLC). A phase II study

【24h】

819 Induction carboplatin-paclitaxel-gemcitabine (CPG) followed by concurrent weekly carboplatin-paclifaxel (CP) and radiation therapy in unresectable stage iii non-small cell lung cancer (NSCLC). A phase II study

机译：819在无法切除的iii期非小细胞肺癌（NSCLC）中，诱导卡铂-紫杉醇-吉西他滨（CPG），然后同时每周进行卡铂-紫杉醇（CP）和放射治疗。 II期研究

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements 》 |2003年第5期| 共1页
作者
O.Francesco; A.Paccagnella; S.Fasan; S.Ardit; C.Gatti; R.Biason; M.Medici; P.dAmanzo; M.G.Ghi; O.Nasicmben;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. 9104 Randomized phase III study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly paclitaxel/carboplatin (PC) with concurrent thoracic radiotherapy (CTR) for patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC): West Japan Thoracic Oncology Group (WJTOG) 0105 [J] . N.Katakami, M.Satouchi, N.Yamamoto, European Journal of Cancer Supplements . 2009 ,第2期

机译：9104丝裂霉素/长春地辛/顺铂（MVP）与每周伊立替康/卡铂（IC）或每周紫杉醇/卡铂（PC）联合胸腔放疗（CTR）的不可切除的III期非小细胞患者的3期随机研究肺癌（NSCLC）：西日本胸腔肿瘤小组（WJTOG）0105
2. Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: final results of a phase II study. [J] . Blanco R, Sole J, Montesinos J, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2008 ,第1期

机译：在不可切除的III期非小细胞肺癌中，顺铂和吉西他滨诱导化疗，然后每周两次进行吉西他滨同步放化疗：II期研究的最终结果。
3. 6602 POSTER Induction docetaxel and cisplatin followed by bi-weekly docetaxel with concurrent thoracic radiotherapy for stage III non-small cell lung cancer (NSCLC). A phase II study conducted by the Galician Lung Cancer Group (GLCG) [J] . J.Casal Rubio, S.Vazquez Estevez, M.Lazaro Quintela, European Journal of Cancer Supplements . 2007 ,第4期

机译：6602 POSTER诱导多西紫杉醇和顺铂，然后每两周一次多西紫杉醇并发胸腔放疗，用于III期非小细胞肺癌（NSCLC）。加利西亚肺癌小组（GLCG）进行的II期研究
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. A Study of Erlotinib Monotherapy and in Combination with Pembrolizumab in Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [D] . Liu, Qiong. 2021

机译：Erlotinib单疗法和蛋白质在先前未处理阶段I-IIIA非小细胞肺癌中的研究
6. GEMSTONE-301: a phase III clinical trial of CS1001 as consolidation therapy in patients with locally advanced/unresectable (stage III) non-small cell lung cancer (NSCLC) who did not have disease progression after prior concurrent/sequential chemoradiotherapy [O] . Qing Zhou, Ming Chen, Gang Wu, 2020

机译：Gemstone-301：CS1001的III期临床试验作为局部晚期/不可切除（第III阶段）非小细胞肺癌（NSCLC）在先前同时/顺序化学疗法后没有疾病进展的患者的固结治疗
7. P2-167: Induction docetaxel and cisplatin followed of bi-weekly docetaxel with concurrent thoracic radiotherapy for stage III non-small cell lung cancer (NSCLC). A phase II study conducted by the Galician Lung Cancer Group (GLCG). [O] . Casal Joaquin R., Vazquez Sergio E., Lázaro Martin Q., 2007

机译：P2-167：对多西他赛和顺铂进行诱导，每两周一次多西他赛，并发胸腔放疗，用于III期非小细胞肺癌（NSCLC）。加利西亚肺癌小组（GLCG）进行的II期研究。

819 Induction carboplatin-paclitaxel-gemcitabine (CPG) followed by concurrent weekly carboplatin-paclifaxel (CP) and radiation therapy in unresectable stage iii non-small cell lung cancer (NSCLC). A phase II study

著录项

相似文献

相关主题

期刊订阅